Pfizer is nearing a significant acquisition, targeting a deal valued at approximately $7.3 billion to buy the weight-loss drug manufacturer Metsera. According to the Financial Times,...
Pfizer is reportedly nearing a significant acquisition, aiming for a takeover of weight-loss drug manufacturer Metsera in a deal valued at approximately $7.3 billion. According to...